Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report)’s share price traded down 2.7% on Thursday . The stock traded as low as €22.90 ($24.89) and last traded at €23.00 ($25.00). 3,641,389 shares were traded during mid-day trading, The stock had previously closed at €23.64 ($25.70).
Bayer Aktiengesellschaft Stock Performance
The company has a market cap of $23.51 billion, a P/E ratio of -26.71, a P/E/G ratio of 36.39 and a beta of 0.97. The firm’s fifty day moving average is €21.59 and its two-hundred day moving average is €23.26.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Read More
- Five stocks we like better than Bayer Aktiengesellschaft
- Investing In Automotive Stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is a support level?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Options Trading – Understanding Strike Price
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
